-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca Mengumumkan Tozorakimab Menunjukkan Pengurangan Peserta Dengan Penyakit Paru-paru Obstruktif Kronik Dalam Fasa III Kajian OBERON, TITANIA

Benzinga·09/08/2026 11:52:02

https://www.astrazeneca.com/media-centre/press-releases/2026/tozorakimab-demonstrated-statistically-significant-highly-clinically-meaningful-reduction-copd-exacerbations-oberon-titania-phase-iii-trials.html